{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:10:40Z","timestamp":1792599040380,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French Research Agency on Infectious and Emerging Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"ANRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031128","name":"PADS","doi-asserted-by":"publisher","award":["23-131"],"award-info":[{"award-number":["23-131"]}],"id":[{"id":"10.13039\/100031128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The impact of pharmacokinetic variability of cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) injectable therapy on virological outcomes remains controversial. This study aimed to characterize the variability of CAB and RPV trough concentrations (Ctrough) and to identify the predictors of suboptimal exposure and virologic failure (VF) in a large real-world cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter observational study including people with human immunodeficiency virus type 1 (HIV-1) initiating LA-CAB\/RPV as maintenance therapy from January to December 2022, in whom CAB and RPV plasma Ctrough were determined as part of therapeutic drug monitoring (TDM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1674 CAB and 1687 RPV Ctrough measurements were collected from 736 people with HIV-1 (PWH). Significant interindividual variability in concentrations was observed. At month 1\/month 3, 20%\u201330% of PWH had Ctrough &amp;lt;1120\u2005ng\/mL for CAB and 32\u2005ng\/mL for RPV. Predictors of lower Ctrough were body mass index (BMI) \u226530\u2005kg\/m2 and female sex at month 1, and only male sex at steady state. After a median follow-up of 12 (interquartile range, 9\u201316) months, VF occurred in 2.5% of PWH. At month 6 and month 12, VF was significantly associated with the presence of at least 2 risk factors (obesity, suboptimal Ctrough) (odds ratio [OR], 4.6, P = .047; OR, 5.15, P = .014), and CD4 nadir (OR, 0.56, P = .008; OR, 0.5, P = .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our large real-world study confirms significant variability in CAB and RPV exposure, with BMI and sex as key predictors of lower Ctrough. Suboptimal CAB and RPV Ctrough, particularly in people with obesity, increases the risk of VF during the first year of treatment, highlighting the usefulness of TDM in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf385","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T11:20:45Z","timestamp":1752837645000},"page":"109-118","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9193-1120","authenticated-orcid":false,"given":"Nad\u00e8ge","family":"N\u00e9ant","sequence":"first","affiliation":[{"name":"APHM, H\u00f4pital La Timone, Laboratoire de Pharmacocin\u00e9tique et Toxicologie, Unit\u00e9 des Virus \u00c9mergents, Aix-Marseille Universit\u00e9, IRD 190, Inserm 1207 , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-8288","authenticated-orcid":false,"given":"Minh P","family":"L\u00ea","sequence":"additional","affiliation":[{"name":"AP-HP Nord, Pharmacology Department, Bichat Claude-Bernard University Hospital , Paris ,","place":["France"]},{"name":"Inserm-UMR 1137, IAME, Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-5505","authenticated-orcid":false,"given":"St\u00e9phane","family":"Bouchet","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie et Toxicologie, Service de Pharmacologie M\u00e9dicale, CHU Pellegrin, Inserm U1219 , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-4778","authenticated-orcid":false,"given":"Jennifer","family":"Lagoutte-Renosi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on, SINERGIES (UR 4662), F-25000 Besan\u00e7on ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-5761","authenticated-orcid":false,"given":"Matthieu","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie Clinique, Nantes Universit\u00e9, CHU Nantes , Nantes ,","place":["France"]},{"name":"CHU Nantes, Nantes Universit\u00e9, Cibles et m\u00e9dicaments des infections et de l\u2019immunit\u00e9, 9 IICiMed, UR 1155 , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Parant","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Groupement Hospitalier Sud-Service de Biochimie et Biologie Mol\u00e9culaire, UM Pharmacologie-Toxicologie , Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7466-6388","authenticated-orcid":false,"given":"Nicolas","family":"Venisse","sequence":"additional","affiliation":[{"name":"CNRS-UMR 7267, CHU de Poitiers, Service de Toxicologie et Pharmacocin\u00e9tique et Inserm-CIC 1402, Universit\u00e9 de Poitiers , Poitiers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-1030","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Lalanne","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, EHESP, Institut de recherche en sant\u00e9, environnement et travail, UMR_S 1085, Universit\u00e9 de Rennes , Rennes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-3629","authenticated-orcid":false,"given":"Florian","family":"Lemaitre","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, EHESP, Institut de recherche en sant\u00e9, environnement et travail, UMR_S 1085, Universit\u00e9 de Rennes , Rennes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Muret","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on, SINERGIES (UR 4662), F-25000 Besan\u00e7on ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Renou","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Virus \u00c9mergents, Aix-Marseille Universit\u00e9, IRD 190, Inserm 1207 , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-9201","authenticated-orcid":false,"given":"Alexandre","family":"Destere","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Universit\u00e9 C\u00f4te d\u2019Azur Medical Centre , Nice ,","place":["France"]},{"name":"Laboratoire J. A. Dieudonn\u00e9, Universit\u00e9 C\u00f4te d\u2019Azur, Inria, CNRS, Maasai Team , Nice ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Gandia","sequence":"additional","affiliation":[{"name":"INTHERES, Universit\u00e9 de Toulouse, INRAE, ENVT , Toulouse ,","place":["France"]},{"name":"Laboratoire de Pharmacocin\u00e9tique et Toxicologie, CHU de Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-3522","authenticated-orcid":false,"given":"Philippe","family":"Flandre","sequence":"additional","affiliation":[{"name":"Inserm UMR-S1136, Sorbonne Universit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-537X","authenticated-orcid":false,"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[{"name":"AP-HP Nord, Pharmacology Department, Bichat Claude-Bernard University Hospital , Paris ,","place":["France"]},{"name":"Inserm-UMR 1137, IAME, Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-9648","authenticated-orcid":false,"given":"Caroline","family":"Solas","sequence":"additional","affiliation":[{"name":"APHM, H\u00f4pital La Timone, Laboratoire de Pharmacocin\u00e9tique et Toxicologie, Unit\u00e9 des Virus \u00c9mergents, Aix-Marseille Universit\u00e9, IRD 190, Inserm 1207 , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ANRS-MIE-CARLAPOP Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gendrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Klopfenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souheil","family":"Zayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Bozon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Hustache-Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgane","family":"Hemssamfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Piroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Mahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Anne","family":"Trabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Alfaiate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Godinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Perpoint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Javaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Motte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Obry-Roguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Br\u00e9gigeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Faucher-Zaegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ravaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dhiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Tomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Million","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Philibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Psomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona-Loredana","family":"Berbescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Drumel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Allavena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Billaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabelline","family":"Bouchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Brunet-Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Deschanvres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Raffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Reliquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwennaelle","family":"Querne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Mear-Passard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Asquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Moyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Beslon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lio","family":"Collias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdanpanah","family":"Yazdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pourcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Valantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Plainchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Benezit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cheneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Ursenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hoellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Melounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2026020904074183800_ciaf385-B1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N Engl J Med"},{"key":"2026020904074183800_ciaf385-B2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000002466","article-title":"Long-acting injectable cabotegravir+ rilpivirine for HIV maintenance therapy: week 48 pooled analysis of phase 3 ATLAS and FLAIR trials","volume":"85","author":"Rizzardini","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026020904074183800_ciaf385-B3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0000000000003025","article-title":"Week 96 extension results of a phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment","volume":"36","author":"Swindells","year":"2022","journal-title":"AIDS"},{"key":"2026020904074183800_ciaf385-B4","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3018(20)30340-4","article-title":"Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study","volume":"8","author":"Orkin","year":"2021","journal-title":"Lancet HIV"},{"key":"2026020904074183800_ciaf385-B5","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0140-6736(20)32666-0","article-title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48\u2013week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","volume":"396","author":"Overton","year":"2020","journal-title":"Lancet"},{"key":"2026020904074183800_ciaf385-B6","author":"ViiV Healthcare"},{"key":"2026020904074183800_ciaf385-B7","author":"Mutuluuza"},{"key":"2026020904074183800_ciaf385-B8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000002883","article-title":"Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis","volume":"35","author":"Cutrell","year":"2021","journal-title":"AIDS"},{"key":"2026020904074183800_ciaf385-B9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/cid\/ciad370","article-title":"Expanded multivariable models to assist patient selection for long-acting cabotegravir + rilpivirine treatment: clinical utility of a combination of patient, drug concentration, and viral factors associated with virologic failure","volume":"77","author":"Orkin","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026020904074183800_ciaf385-B10","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/jac\/dkab338","article-title":"Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV","volume":"76","author":"Neyens","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026020904074183800_ciaf385-B11","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1111\/bcp.15439","article-title":"Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1\u2013infected and uninfected subjects","volume":"88","author":"Han","year":"2022","journal-title":"Brit J Clin Pharmacol"},{"key":"2026020904074183800_ciaf385-B12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/bcp.14977","article-title":"Multiparametric magnetic resonance imaging to characterize cabotegravir long-acting formulation depot kinetics in healthy adult volunteers","volume":"88","author":"Jucker","year":"2022","journal-title":"Brit J Clin Pharmacol"},{"key":"2026020904074183800_ciaf385-B13","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2352-3018(20)30106-5","article-title":"Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial","volume":"7","author":"Landovitz","year":"2020","journal-title":"Lancet HIV"},{"key":"2026020904074183800_ciaf385-B14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1473-3099(15)00152-8","article-title":"Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial","volume":"15","author":"Margolis","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2026020904074183800_ciaf385-B15","author":"International Conference on Harmonisation","year":"1996"},{"key":"2026020904074183800_ciaf385-B16","author":"World Medical Association"},{"key":"2026020904074183800_ciaf385-B17","author":"ANRS-MIE\u2013AC43 Pharmacologic and Resistance Group"},{"key":"2026020904074183800_ciaf385-B18","doi-asserted-by":"crossref","first-page":"100793","DOI":"10.1016\/j.lanepe.2023.100793","article-title":"Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland","volume":"36","author":"Thoueille","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026020904074183800_ciaf385-B19","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/jac\/dkae308","article-title":"Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror phase 3 results","volume":"79","author":"Serris","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026020904074183800_ciaf385-B20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jac\/dkae080","article-title":"Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals","volume":"79","author":"Cossu","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026020904074183800_ciaf385-B21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/QAD.0000000000003887","article-title":"Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine","volume":"38","author":"Rubenstein","year":"2024","journal-title":"AIDS"},{"key":"2026020904074183800_ciaf385-B22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/cid\/ciae475","article-title":"Virological history predicts non-sustained viral suppression with long-acting cabotegravir and rilpivirine therapy, independent of pharmacokinetic parameters","volume":"80","author":"Guti\u00e9rrez","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026020904074183800_ciaf385-B23","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1016\/S2352-3018(21)00184-3","article-title":"Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study","volume":"8","author":"Orkin","year":"2021","journal-title":"Lancet HIV"},{"key":"2026020904074183800_ciaf385-B24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/cpt.3240","article-title":"Population pharmacokinetics of cabotegravir following oral administration and long-acting intramuscular injection in real-world people with HIV","volume":"115","author":"Thoueille","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"2026020904074183800_ciaf385-B25","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/infdis\/jiad580","article-title":"Efficacy, safety, and pharmacokinetics by body mass index category in phase 3\/3b long-acting cabotegravir plus rilpivirine trials","volume":"230","author":"Elliot","year":"2024","journal-title":"J Infect Dis"},{"key":"2026020904074183800_ciaf385-B26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/cid\/ciae060","article-title":"Effect of obesity on the exposure of long-acting cabotegravir and rilpivirine: a modeling study","volume":"79","author":"Bettonte","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026020904074183800_ciaf385-B27","first-page":"1137","article-title":"Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case\u2013control study","volume":"72","author":"Madelain","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026020904074183800_ciaf385-B28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40262-022-01132-3","article-title":"Repository describing the anatomical, physiological, and biological changes in an obese population to inform physiologically based pharmacokinetic models","volume":"61","author":"Berton","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"2026020904074183800_ciaf385-B29","doi-asserted-by":"crossref","first-page":"ofad217","DOI":"10.1093\/ofid\/ofad217","article-title":"Gynoid fat distribution and adipocyte trapping may explain virological failure with intramuscular long-acting cabotegravir and rilpivirine","volume":"10","author":"De Malliard","year":"2023","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf385\/64070321\/ciaf385.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/1\/109\/64070321\/ciaf385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/1\/109\/64070321\/ciaf385.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:07:50Z","timestamp":1770628070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/1\/109\/8236679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,18]]},"published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf385","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,15]]},"published":{"date-parts":[[2025,8,18]]}}}